Transient inhibition of interleukin 4 signaling by T cell receptor ligation

被引:52
作者
Zhu, JF [1 ]
Huang, H [1 ]
Guo, LY [1 ]
Stonehouse, T [1 ]
Watson, CJ [1 ]
Hu-Li, J [1 ]
Paul, WE [1 ]
机构
[1] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
关键词
cytokine signal transduction; T cell activation and differentiation; cross-talk; calcineurin; mitogen-activated protein kinase;
D O I
10.1084/jem.192.8.1125
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin (IL)-4 and IL-12 together with T cell receptor (TCR) engagement are crucial for the differentiation of CD4+ T cells into T helper (Th)2 or Th1 cells, respectively. Although IL-4 receptors (IL-4Rs) but not IL-12Rs are expressed on naive CD4(+) T cells, IL-4 has no apparent advantage over IL-12 in driving naive T cell differentiation when the cells are primed with both IL-4 and IL-12 in vitro. It was found that IL-4-induced phosphorylation of Janus kinases 1 and 3, IL-4R alpha, signal transducer and activator of transcription 6, and insulin receptor substrate 2 was strikingly but transiently inhibited by TCR Ligation both in conventional and TCR transgenic T cells, TCR engagement also blocked the expression of an IL-4-inducible gene. Signals induced by other cytokines, including IL-e, IL-6, and interferon alpha, but not by insulin-like growth factor 1, were also blocked by TCR engagement. The capacity of various inhibitors to reverse TCR-mediated inhibition of IL-4 signaling suggested that activation of the Ras-mitogen-activated protein kinase pathway and of the calcineurin pathway contribute to desensitizing IL-4R. IL-4 responsiveness returned at about the time (similar to 12 h) that IL-12-mediated signaling was first observed. Thus, through different mechanisms, neither IL-4R nor IL-12R has any clear advantage in polarizing cells; rather, the availability of cytokine is probably the limiting factor in this process.
引用
收藏
页码:1125 / 1134
页数:10
相关论文
共 48 条
[1]   T cell antigen receptor signal transduction pathways [J].
Cantrell, D .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :259-274
[2]  
Chen D, 1999, J IMMUNOL, V163, P5796
[3]   Jak1 expression is required for mediating interleukin-4 induced tyrosine phosphorylation of insulin receptor substrate and state signaling molecules [J].
Chen, XH ;
Patel, BKR ;
Wang, LM ;
Frankel, M ;
Ellmore, N ;
Flavell, RA ;
LaRochelle, WJ ;
Pierce, JH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) :6556-6560
[4]   HUMAN RECOMBINANT INTERLEUKIN-4 INDUCES FC-EPSILON RECEPTORS (CD23) ON NORMAL HUMAN LYMPHOCYTES-B [J].
DEFRANCE, T ;
AUBRY, JP ;
ROUSSET, F ;
VANBERVLIET, B ;
BONNEFOY, JY ;
ARAI, N ;
TAKEBE, Y ;
YOKOTA, T ;
LEE, F ;
ARAI, K ;
DEVRIES, J ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (06) :1459-1467
[5]   Inhibition of IL-4-inducible gene expression in human monocytes by type I and type II interferons [J].
Dickensheets, HL ;
Donnelly, RP .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (03) :307-312
[6]   Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression [J].
Dickensheets, HL ;
Venkataraman, C ;
Schindler, U ;
Donnelly, RP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (19) :10800-10805
[7]   A new protein containing an SH2 domain that inhibits JAK kinases [J].
Endo, TA ;
Masuhara, M ;
Yokouchi, M ;
Suzuki, R ;
Sakamoto, H ;
Mitsui, K ;
Matsumoto, A ;
Tanimura, S ;
Ohtsubo, M ;
Misawa, H ;
Miyazaki, T ;
Leonor, N ;
Taniguchi, T ;
Fujita, T ;
Kanakura, Y ;
Komiya, S ;
Yoshimura, A .
NATURE, 1997, 387 (6636) :921-924
[8]  
Himmelrich H, 1998, J IMMUNOL, V161, P6156
[9]   INTERLEUKIN-12 SIGNALING IN T-HELPER TYPE-1 (TH1) CELLS INVOLVES TYROSINE PHOSPHORYLATION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT)3 AND STAT4 [J].
JACOBSON, NG ;
SZABO, SJ ;
WEBERNORDT, RM ;
ZHONG, Z ;
SCHREIBER, RD ;
DARNELL, JE ;
MURPHY, KM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1755-1762
[10]   Triggering the TCR complex causes the downregulation of nonengaged receptors by a signal transduction-dependent mechanism [J].
José, ES ;
Borroto, A ;
Niedergang, F ;
Alcover, A ;
Alarcón, B .
IMMUNITY, 2000, 12 (02) :161-170